Decoding the Genetic Mysteries of Malaria Susceptibility

Malaria, severe, susceptibility to

Expert Reviewed By: Dr. Brandon Colby MD

Understanding Malaria Susceptibility and Its Genetic Factors

Malaria, a life-threatening disease caused by the Plasmodium parasite, continues to be a global health concern. While some individuals seem to be more resistant to the disease, others are highly susceptible to severe malaria and its complications. Recent studies have shed light on the genetic factors that influence an individual's susceptibility to malaria, providing valuable insights into disease prevention and potential treatment strategies.

One such study, "Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya", found that genetic variation in the CSF2 gene influences susceptibility to malaria, severe malarial anemia, and mortality, as well as age, HIV-1 status, and inheritance of HbSS. Another study, "The first genes for susceptibility to cerebral malaria in Angolan children identified", identified the first genetic risk factors for the development of cerebral malaria in Angolan children, a severe manifestation of malaria infection.

Diagnosing Malaria and Identifying Genetic Susceptibility

Diagnosing malaria typically involves examining a blood sample under a microscope to detect the presence of the Plasmodium parasite. However, understanding an individual's genetic susceptibility to severe malaria can provide valuable information for healthcare providers in determining the best course of treatment and prevention strategies.

Genetic testing can help identify individuals who may be more susceptible to severe malaria due to specific genetic variations. A comprehensive review, "Genetic factors that confer resistance and susceptibility to malaria", summarizes genetic variations related to resistance and susceptibility to malaria, including red blood cell (RBC) variants, pathogen receptors, cyto-adherence, inflammation, and immunity.

Uses of Genetic Testing for Malaria Susceptibility

Genetic testing for malaria susceptibility can provide several benefits, including:

  • Personalized prevention strategies: Identifying individuals with a higher genetic susceptibility to severe malaria can help healthcare providers devise personalized prevention strategies, such as targeted use of antimalarial drugs and insecticide-treated bed nets.
  • Early intervention and treatment: Early identification of individuals at higher risk of severe malaria can lead to prompt intervention and treatment, potentially reducing the severity of the disease and preventing complications.
  • Improved understanding of disease mechanisms: Genetic testing can provide insights into the biological mechanisms underlying malaria susceptibility and resistance, potentially leading to the development of new treatment strategies and interventions.

Genome-Wide Association Studies and Malaria Susceptibility

Genome-wide association studies (GWASs) have been instrumental in identifying genetic factors associated with malaria susceptibility. A review, "Genome-Wide Association Studies of malaria susceptibility and resistance: progress, pitfalls, and prospects", assesses the progress and pitfalls of malaria susceptibility GWASs and discusses post-GWAS approaches for extracting further functional information.

As more genetic factors associated with malaria susceptibility are identified, researchers can continue to refine our understanding of the disease and develop targeted interventions. Genetic testing for malaria susceptibility may soon become a valuable tool in the global fight against this devastating disease.

About The Expert Reviewer

Dr. Brandon Colby MD is a US physician specializing in the personalized prevention of disease through the use of genomic technologies. He’s an expert in genetic testing, genetic analysis, and precision medicine. Dr. Colby is also the Founder of  and the author of ⁠Outsmart Your Genes.

Dr. Colby holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University’s Graduate School of Business, and a degree in Genetics with Honors from the University of Michigan. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (⁠ACMG), an Associate of the American College of Preventive Medicine (⁠ACPM), and a member of the National Society of Genetic Counselors (NSGC)

View more articles like this